Annual balance sheet for BioCardia, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 12.9 | 7.36 | 1.1 | 2.37 | 2.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.147 | 0.201 | 0.063 | 0 | 0.02 |
| Prepaid Expenses | |||||
| Total Current Assets | 13.5 | 7.86 | 1.46 | 2.62 | 2.73 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.06 | 1.76 | 1.35 | 0.931 | 0.51 |
| Other Long Term Assets | |||||
| Total Assets | 15.7 | 9.79 | 2.99 | 3.72 | 3.41 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.71 | 3.58 | 3.61 | 2.32 | 2.43 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.34 | 4.9 | 4.59 | 2.89 | 2.52 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 10.4 | 4.89 | -1.6 | 0.837 | 0.895 |
| Total Liabilities & Shareholders' Equity | 15.7 | 9.79 | 2.99 | 3.72 | 3.41 |
| Total Common Shares Outstanding |